ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

ONWD Onward Medical NV

4.73
-0.11 (-2.27%)
10 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Onward Medical NV ONWD Euronext Acción Ordinaria
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.11 -2.27% 4.73 10:40:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
4.94 4.70 4.94 4.73 4.84
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/5/202420:31GLOBEAvis de convocation à l’assemblée générale 2024 des..
02/5/202400:00GLOBEONWARD® Medical Convocation of the 2024 Annual General..
26/4/202408:17GLOBEONWARD® Medical annonce ses résultats financiers et..
25/4/202400:30GLOBEONWARD® Medical Reports Full Year 2023 Financial and..
11/4/202400:30GLOBEONWARD® Medical Announces Publication of Full Year 2023..
09/4/202400:00GLOBEStifel Initiates Research Coverage of ONWARD® Medical with a..
02/4/202400:30GLOBEONWARD® Medical Submits De Novo Application to FDA for its..
25/3/202411:40GLOBEONWARD® Medical Publishes Closing of Accelerated Bookbuild..
21/3/202412:26GLOBEONWARD® Medical Publishes Prospectus for Listing of New..
20/3/202421:03GLOBEONWARD® Medical Lève avec Succès 20 millions d'euros dans le..
20/3/202412:29UKREGONWARD® Medical Launches Capital Increase by Way of an..
20/3/202412:29GLOBEONWARD® Medical Launches Capital Increase by Way of an..
20/3/202412:24UKREGONWARD® Medical Lance une Augmentation de Capital par le..
20/3/202412:24GLOBEONWARD® Medical Launches Capital Increase by Way of an..
20/3/202412:24UKREGONWARD® Medical Launches Capital Increase by Way of an..
18/3/202401:30GLOBEONWARD® Medical Successfully Completes Benchmark Testing on..
15/3/202401:30GLOBEONWARD renforce son management avec des nominations clés..
11/3/202401:30GLOBEONWARD® Medical Accepted to New US FDA TAP Program for..
29/2/202400:41GLOBEONWARD® Medical Awarded 10th Breakthrough Device Designation..
09/2/202400:30GLOBEKBC Securities Initiates Research Coverage of ONWARD®..
07/2/202414:55GLOBEONWARD® MEDICAL ANNOUNCES PRESENTATION AT BIOCAPITAL EUROPE
25/1/202416:11GLOBEONWARD® ARC Therapy™ Highlighted at 2024 Annual Meeting of..
22/1/202413:03GLOBEONWARD® to Participate in Basel Healthtech Conference 2024
19/1/202411:48GLOBEONWARD® to Participate in Degroof Petercam Healthcare..
18/1/202400:30GLOBEONWARD® Announces Start of HemON NL Clinical Study
16/11/202300:30GLOBEONWARD renforce son management avec des nominations clés..
06/11/202311:13GLOBEONWARD verstärkt Führungsteam auf Schlüsselpositionen in den..
11/10/202312:43GLOBEONWARD Schedules Webcast to Provide Third Quarter 2023..
27/9/202300:30GLOBEONWARD® Announces First-in-Human Implant of ARC-IM™..
18/9/202323:30GLOBEONWARD® publie ses résultats semestriels 2023 et fait le..
13/9/202311:40GLOBEONWARD® lance un partenariat avec une entreprise appartenant..
05/9/202319:23GLOBEONWARD prévoit une webdiffusion pour fournir une mise à jour..
24/5/202310:30GLOBEBrain Computer Interface (BCI) Enables Thought-Controlled..
16/5/202300:30GLOBEONWARD Reports Q1 Business Update and Year-To-Date..
15/5/202310:30GLOBEONWARD gibt erstmalige Anwendung der ARC-IM™-Elektrode zur..

Su Consulta Reciente

Delayed Upgrade Clock